Clinical Trials
3
Trial Phases
1 Phases
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (2 trials with phase data)• Click on a phase to view related trials
CIS001 Extension Study of Cyclosporine Inhalation Solution
- First Posted Date
- 2009-07-13
- Last Posted Date
- 2012-09-17
- Lead Sponsor
- APT Pharmaceuticals, Inc.
- Target Recruit Count
- 17
- Registration Number
- NCT00938236
- Locations
- 🇺🇸
UCLA School of Medicine, Los Angeles, California, United States
🇺🇸University of California, San Francisco, San Francisco, California, United States
🇺🇸Stanford University Medical Center, Stanford, California, United States
Study of Cyclosporine Inhalation Solution (CIS) in Improving Bronchiolitis Obliterans Syndrome-Free Survival Following Lung Transplantation
- First Posted Date
- 2008-09-19
- Last Posted Date
- 2012-09-17
- Lead Sponsor
- APT Pharmaceuticals, Inc.
- Target Recruit Count
- 284
- Registration Number
- NCT00755781
- Locations
- 🇺🇸
UCLA School of Medicine, Los Angeles, California, United States
🇺🇸University of California, San Francisco, San Francisco, California, United States
🇺🇸Stanford University Medical Center, Stanford, California, United States
Cyclosporine Inhalation Solution (CIS) in Lung Transplant Recipients
- Conditions
- Lung Transplant
- First Posted Date
- 2008-03-12
- Last Posted Date
- 2012-09-17
- Lead Sponsor
- APT Pharmaceuticals, Inc.
- Registration Number
- NCT00633373
- Locations
- 🇺🇸
University of California at San Francisco, San Francisco, California, United States
🇺🇸University of Florida Health Sciences Center, Gainesville, Florida, United States
🇺🇸Tampa General Hospital, Tampa, Florida, United States